These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 1598872)
1. Myocardial adenine nucleotide concentrations and myocardial norepinephrine content in patients with heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Regitz V; Fleck E Am J Cardiol; 1992 Jun; 69(19):1574-80. PubMed ID: 1598872 [TBL] [Abstract][Full Text] [Related]
2. Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases. Regitz V; Shug AL; Fleck E Am J Cardiol; 1990 Mar; 65(11):755-60. PubMed ID: 2316456 [TBL] [Abstract][Full Text] [Related]
3. Myocardial high-energy phosphate levels in cardiomyopathic turkeys. St Cyr J; Bianco R; Foker J; Noren G; Staley N; Wang TC; Einzig S J Surg Res; 1986 Sep; 41(3):256-9. PubMed ID: 3762130 [TBL] [Abstract][Full Text] [Related]
4. Adenine nucleotide metabolism and contractile dysfunction in heart failure--biochemical aspects, animal experiments, and human studies. Regitz V; Fleck E Basic Res Cardiol; 1992; 87 Suppl 1():321-9. PubMed ID: 1497576 [TBL] [Abstract][Full Text] [Related]
5. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy. Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807 [TBL] [Abstract][Full Text] [Related]
6. Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins. Regitz V; Leuchs B; Bossaller C; Sehested J; Rappolder M; Fleck E Eur Heart J; 1991 Aug; 12 Suppl D():171-4. PubMed ID: 1915450 [TBL] [Abstract][Full Text] [Related]
7. Human myocardial ATP content and in vivo contractile function. Starling RC; Hammer DF; Altschuld RA Mol Cell Biochem; 1998 Mar; 180(1-2):171-7. PubMed ID: 9546644 [TBL] [Abstract][Full Text] [Related]
9. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Neubauer S; Krahe T; Schindler R; Horn M; Hillenbrand H; Entzeroth C; Mader H; Kromer EP; Riegger GA; Lackner K Circulation; 1992 Dec; 86(6):1810-8. PubMed ID: 1451253 [TBL] [Abstract][Full Text] [Related]
10. Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy. Schultheiss HP Basic Res Cardiol; 1992; 87 Suppl 1():311-20. PubMed ID: 1497575 [TBL] [Abstract][Full Text] [Related]
11. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy. Kalsi KK; Smolenski RT; Pritchard RD; Khaghani A; Seymour AM; Yacoub MH Eur J Clin Invest; 1999 Jun; 29(6):469-77. PubMed ID: 10354207 [TBL] [Abstract][Full Text] [Related]
12. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Brillantes AM; Allen P; Takahashi T; Izumo S; Marks AR Circ Res; 1992 Jul; 71(1):18-26. PubMed ID: 1318794 [TBL] [Abstract][Full Text] [Related]
13. Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity. Parissis JT; Adamopoulos SN; Venetsanou KF; Karas SM; Kremastinos DT J Interferon Cytokine Res; 2003 Jun; 23(6):329-33. PubMed ID: 12859859 [TBL] [Abstract][Full Text] [Related]